Pathogenesis of psoriasis and current challenges

J Cutan Med Surg. 2004 Aug:8 Suppl:3-7. doi: 10.1007/s10227-004-2002-7.
No abstract available

MeSH terms

  • Alefacept
  • Humans
  • Lymphocyte Activation
  • Psoriasis / drug therapy
  • Psoriasis / immunology
  • Psoriasis / physiopathology*
  • Quality of Life
  • Recombinant Fusion Proteins / therapeutic use
  • Remission Induction
  • T-Lymphocytes / immunology
  • T-Lymphocytes / physiology*

Substances

  • Recombinant Fusion Proteins
  • Alefacept